KB Home is a homebuilding company. The company builds a variety of homes designed primarily for first-time and first move-up, as well as second move-up and active adult homebuyers, including attached and detached single-family residential homes, townhomes and condominiums. The company's financial services operations provide various insurance products to its homebuyers in the markets where it builds homes and provide title services in certain of those markets. The company's financial services operations also provide mortgage banking services, including residential consumer mortgage loan originations, to its homebuyers indirectly through KBHS Home Loans, LLC, a joint venture the company formed with Stearns Lending, LLC.
  • TickerKBH
  • ISINUS48666K1097
  • ExchangeNew York Stock Exchange
  • SectorHousehold Goods & Home Construction
  • CountryUnited States
Jay McCanless

Flipping the Script on Order Growth to Positive from Negative

KB Home: Update to credit analysis

Our credit view of KB Home's credit profile, highlighting the company's market position as one of the ten largest homebuilders in the US

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

• A number of Consumer Cyclical names continue to indicate leadership. (ex. THO, WGO, CROX, WLH, LEN, KBH, PZZA, TXRH, SCVL, GCO, and RH) • The Healthcare Sector has a number of attractive names developing major bases and staging RS reversals. (ex. CAH, HSIC, ITGR, ABT, MLAB, RMD, SYK, MD, RDNT, TRHC, CNC, WCG, RGNX, BEO, and SYNH) • The Technology Sector continues to be long-term leadership. Many issues are extended and we would suggest taking opportunity of any weakness. (ex. TER, AMAT, SYNA, INTC, AVGO, INTU, LPSN, CTXS, ADP, EXLS, PRSP, and FN)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Treasury yields tell the tale As Treasury yields began moving off the lows on 9/5/19 due to a variety of factors, investors took profits from large-caps, growth, and defensives and migrated to small-caps, value, and cyclicals. This was a shift from areas of obvious leadership to areas that had been left for dead, something that, if it can continue, would greatly improve the prospects of a broad-based move higher. However, a primary concern of ours is whether this shift has staying power. As we highlight below, we believe the jury is still out, leaving our overall neutral outlook intact. • Tr...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Despite weakness in a number of Consumer Discretionary stocks, there are a number of names that remain attractive (ex. KBH, PHM, SIX, RRGB, WEN, SHAK, DNKN, and WMT) • The Consumer Staples Sector continues to have a number of leadership names. (ex. HSY, K, SAFM, VGR, and CHD) • Gold remains a leadership area of the market. (ex. RGLD, and NEM) • REITs and Utilities are increasingly moving as market leadership. (ex. OHI, WELL, LTC, DEA, IRT, EQR, UDR, ADC, EXR, CONE, NSA, AMT, NEE, IDA, DUK, and ES)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Caution remains warranted We have noted several times throughout the month of August that key support levels were being tested for global equities (8/6 Compass and 8/8, 8/15, & 8/22 Int'l Compass), and while there has yet to be a decisive breakdown, as time has passed there has been new negative developments which lead us to be even more cautious. This past Friday's test of support is no different, and we believe the market is more vulnerable to a breakdown than it has been at any other point this year. Below we highlight the new concerning developments which lead us to believe the market rem...

KB Home: 1 director sold

A director at KB Home sold 15,000 shares at 39.620USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board member...

Jay McCanless

Flipping the Script on Order Growth to Positive from Negative

KB Home: Update to credit analysis

Our credit view of KB Home's credit profile, highlighting the company's market position as one of the ten largest homebuilders in the US

KB Home - November 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

KB Home - August 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

KB Home: Covenant Quality Post-Sale Snapshot: $300m 4.800% Senior Notes due 2029

KB Home’s covenant package provides middle-tier HY-lite protection, reflecting a covenant quality score of 5.00.

Moody's announces completion of a periodic review of ratings of KB Home

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of KB Home. Global Credit Research- 01 Nov 2019. New York, November 01, 2019-- Moody's Investors Service has completed a periodic review of the ratings of KB Home and other ratings that are associated with the same analytical unit.

KB HOME sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of KB HOME (US), active in the Home Construction industry. As regards its fundamental valuation, the title now shows 2 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date June 26, 2020, the closing price was USD 28.58 and its target price was estimated at USD 17.32.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch